
LABT vs XBIO
$LABT vs $XBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
LABT vs XBIO: the quick read
- ·XBIO is the larger company by market cap ($5M vs $5M).
- ·LABT has been more active on our scanner (86 vs 21 alerts in 30 days).
- ·XBIO has the smaller float (2.2M vs 2.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·LABT draws far more of our scanner's attention, 86 unusual-volume alerts in 30 days against 21, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 4% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·XBIO is the one in play today, trading about 5.9x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing LABT and XBIO on TheDesperateTrader.
- Is LABT or XBIO the better stock?
- "Better" depends on your goal, and these two are not alike. XBIO is the larger company by market cap ($5M vs $5M). LABT has been more active on our scanner (86 vs 21 alerts in 30 days). XBIO has the smaller float (2.2M vs 2.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between LABT and XBIO?
- The differences that matter: they are not in the same business - LABT is pharmaceutical preparations and XBIO is pharmaceutical preparations; they are similar in size ($5M vs $5M); they trade at very different share prices ($2.00 vs $2.50); LABT sits at 17% of its 52-week range against 5% for XBIO; our scanner flagged LABT 86 times in the last 30 days against 21 for XBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of LABT and XBIO is more active right now?
- Right now LABT is at about 0.2x its normal volume and XBIO is at about 5.9x, so XBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading LABT or XBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.